XTX Topco’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,053
| Closed | -$290 | – | 3397 |
|
|
2025
Q1 | $290 | Sell |
10,053
-71,407
| -88% | -$2.06K | ﹤0.01% | 2329 |
|
|
2024
Q4 | $18.7K | Buy |
81,460
+52,626
| +183% | +$12.1K | ﹤0.01% | 2044 |
|
|
2024
Q3 | $62K | Buy |
+28,834
| New | +$62K | ﹤0.01% | 1660 |
|
|
2024
Q2 | – | Sell |
-10,949
| Closed | -$58.6K | – | 2587 |
|
|
2024
Q1 | $58.6K | Sell |
10,949
-57
| -0.5% | -$305 | 0.01% | 1448 |
|
|
2023
Q4 | $85.7K | Buy |
+11,006
| New | +$85.7K | 0.02% | 1146 |
|
|
2022
Q2 | – | Sell |
-4,456
| Closed | -$53K | – | 1157 |
|
|
2022
Q1 | $53K | Buy |
4,456
+3,304
| +287% | +$39.3K | 0.02% | 586 |
|
|
2021
Q4 | $38K | Buy |
+1,152
| New | +$38K | 0.02% | 591 |
|
|
2021
Q3 | – | Sell |
-2,602
| Closed | -$142K | – | 1126 |
|
|
2021
Q2 | $142K | Buy |
2,602
+1,485
| +133% | +$81K | 0.05% | 613 |
|
|
2021
Q1 | $84K | Buy |
+1,117
| New | +$84K | 0.04% | 580 |
|